Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer
Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age g...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Piedimonte, Sabrina [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2021 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes - Gibson, Diane M. ELSEVIER, 2017, an international journal : official publication of the Society of Gynecologic Oncologists [u.a.], Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:162 ; year:2021 ; pages:313 |
| Links: |
|---|
| DOI / URN: |
10.1016/S0090-8258(21)01245-2 |
|---|
| Katalog-ID: |
ELV05494614X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV05494614X | ||
| 003 | DE-627 | ||
| 005 | 20230624214925.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1016/S0090-8258(21)01245-2 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica |
| 035 | |a (DE-627)ELV05494614X | ||
| 035 | |a (ELSEVIER)S0090-8258(21)01245-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.11 |2 bkl | ||
| 100 | 1 | |a Piedimonte, Sabrina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. | ||
| 700 | 1 | |a Bernardini, Marcus |4 oth | |
| 700 | 1 | |a May, Taymaa |4 oth | |
| 700 | 1 | |a Laframboise, Stephane |4 oth | |
| 700 | 1 | |a Ferguson, Sarah |4 oth | |
| 700 | 1 | |a Bouchard-Fortier, Genevieve |4 oth | |
| 700 | 1 | |a Cybulska, Paulina |4 oth | |
| 700 | 1 | |a Hogen, Liat |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Gibson, Diane M. ELSEVIER |t Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |d 2017 |d an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] |g Orlando, Fla |w (DE-627)ELV000708127 |
| 773 | 1 | 8 | |g volume:162 |g year:2021 |g pages:313 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S0090-8258(21)01245-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.11 |j Präventivmedizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 162 |j 2021 |h 313 |y 162.2021, S313- | ||
| author_variant |
s p sp |
|---|---|
| matchkey_str |
piedimontesabrinabernardinimarcusmaytaym:2021----:ramnotoeadrdcieatriptet7yasnodr |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.11 |
| publishDate |
2021 |
| allfields |
10.1016/S0090-8258(21)01245-2 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV05494614X (ELSEVIER)S0090-8258(21)01245-2 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Piedimonte, Sabrina verfasserin aut Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. Bernardini, Marcus oth May, Taymaa oth Laframboise, Stephane oth Ferguson, Sarah oth Bouchard-Fortier, Genevieve oth Cybulska, Paulina oth Hogen, Liat oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:162 year:2021 pages:313 https://doi.org/10.1016/S0090-8258(21)01245-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 162 2021 313 162.2021, S313- |
| spelling |
10.1016/S0090-8258(21)01245-2 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV05494614X (ELSEVIER)S0090-8258(21)01245-2 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Piedimonte, Sabrina verfasserin aut Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. Bernardini, Marcus oth May, Taymaa oth Laframboise, Stephane oth Ferguson, Sarah oth Bouchard-Fortier, Genevieve oth Cybulska, Paulina oth Hogen, Liat oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:162 year:2021 pages:313 https://doi.org/10.1016/S0090-8258(21)01245-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 162 2021 313 162.2021, S313- |
| allfields_unstemmed |
10.1016/S0090-8258(21)01245-2 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV05494614X (ELSEVIER)S0090-8258(21)01245-2 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Piedimonte, Sabrina verfasserin aut Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. Bernardini, Marcus oth May, Taymaa oth Laframboise, Stephane oth Ferguson, Sarah oth Bouchard-Fortier, Genevieve oth Cybulska, Paulina oth Hogen, Liat oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:162 year:2021 pages:313 https://doi.org/10.1016/S0090-8258(21)01245-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 162 2021 313 162.2021, S313- |
| allfieldsGer |
10.1016/S0090-8258(21)01245-2 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV05494614X (ELSEVIER)S0090-8258(21)01245-2 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Piedimonte, Sabrina verfasserin aut Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. Bernardini, Marcus oth May, Taymaa oth Laframboise, Stephane oth Ferguson, Sarah oth Bouchard-Fortier, Genevieve oth Cybulska, Paulina oth Hogen, Liat oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:162 year:2021 pages:313 https://doi.org/10.1016/S0090-8258(21)01245-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 162 2021 313 162.2021, S313- |
| allfieldsSound |
10.1016/S0090-8258(21)01245-2 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica (DE-627)ELV05494614X (ELSEVIER)S0090-8258(21)01245-2 DE-627 ger DE-627 rakwb 610 VZ 44.11 bkl Piedimonte, Sabrina verfasserin aut Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. Bernardini, Marcus oth May, Taymaa oth Laframboise, Stephane oth Ferguson, Sarah oth Bouchard-Fortier, Genevieve oth Cybulska, Paulina oth Hogen, Liat oth Enthalten in Academic Press Gibson, Diane M. ELSEVIER Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes 2017 an international journal : official publication of the Society of Gynecologic Oncologists [u.a.] Orlando, Fla (DE-627)ELV000708127 volume:162 year:2021 pages:313 https://doi.org/10.1016/S0090-8258(21)01245-2 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.11 Präventivmedizin VZ AR 162 2021 313 162.2021, S313- |
| source |
Enthalten in Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes Orlando, Fla volume:162 year:2021 pages:313 |
| sourceStr |
Enthalten in Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes Orlando, Fla volume:162 year:2021 pages:313 |
| format_phy_str_mv |
Article |
| bklname |
Präventivmedizin |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| authorswithroles_txt_mv |
Piedimonte, Sabrina @@aut@@ Bernardini, Marcus @@oth@@ May, Taymaa @@oth@@ Laframboise, Stephane @@oth@@ Ferguson, Sarah @@oth@@ Bouchard-Fortier, Genevieve @@oth@@ Cybulska, Paulina @@oth@@ Hogen, Liat @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000708127 |
| dewey-sort |
3610 |
| id |
ELV05494614X |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05494614X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624214925.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0090-8258(21)01245-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05494614X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0090-8258(21)01245-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Piedimonte, Sabrina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bernardini, Marcus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">May, Taymaa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laframboise, Stephane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferguson, Sarah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bouchard-Fortier, Genevieve</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cybulska, Paulina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hogen, Liat</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Gibson, Diane M. ELSEVIER</subfield><subfield code="t">Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes</subfield><subfield code="d">2017</subfield><subfield code="d">an international journal : official publication of the Society of Gynecologic Oncologists [u.a.]</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000708127</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:162</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:313</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0090-8258(21)01245-2</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.11</subfield><subfield code="j">Präventivmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">162</subfield><subfield code="j">2021</subfield><subfield code="h">313</subfield><subfield code="y">162.2021, S313-</subfield></datafield></record></collection>
|
| author |
Piedimonte, Sabrina |
| spellingShingle |
Piedimonte, Sabrina ddc 610 bkl 44.11 Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| authorStr |
Piedimonte, Sabrina |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000708127 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.11 bkl Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| topic |
ddc 610 bkl 44.11 |
| topic_unstemmed |
ddc 610 bkl 44.11 |
| topic_browse |
ddc 610 bkl 44.11 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m b mb t m tm s l sl s f sf g b f gbf p c pc l h lh |
| hierarchy_parent_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| hierarchy_parent_id |
ELV000708127 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000708127 |
| title |
Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| ctrlnum |
(DE-627)ELV05494614X (ELSEVIER)S0090-8258(21)01245-2 |
| title_full |
Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| author_sort |
Piedimonte, Sabrina |
| journal |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| journalStr |
Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
313 |
| author_browse |
Piedimonte, Sabrina |
| container_volume |
162 |
| class |
610 VZ 44.11 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Piedimonte, Sabrina |
| doi_str_mv |
10.1016/S0090-8258(21)01245-2 |
| dewey-full |
610 |
| title_sort |
treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| title_auth |
Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| abstract |
Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. |
| abstractGer |
Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. |
| abstract_unstemmed |
Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer |
| url |
https://doi.org/10.1016/S0090-8258(21)01245-2 |
| remote_bool |
true |
| author2 |
Bernardini, Marcus May, Taymaa Laframboise, Stephane Ferguson, Sarah Bouchard-Fortier, Genevieve Cybulska, Paulina Hogen, Liat |
| author2Str |
Bernardini, Marcus May, Taymaa Laframboise, Stephane Ferguson, Sarah Bouchard-Fortier, Genevieve Cybulska, Paulina Hogen, Liat |
| ppnlink |
ELV000708127 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/S0090-8258(21)01245-2 |
| up_date |
2024-07-06T23:08:39.354Z |
| _version_ |
1803872967699988480 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV05494614X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624214925.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/S0090-8258(21)01245-2</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001487.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV05494614X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0090-8258(21)01245-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.11</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Piedimonte, Sabrina</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Treatment outcomes and predictive factors in patients 70 years and older with advanced ovarian cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) have shown similar survival in patients with advanced ovarian cancer (AOC). However, patients >70 or =70 years old are under-represented in these trials and the extent of surgical effort that can be safely tolerated in this age group is yet to be determined. Our objective was to compare surgical outcome, complication profile and survival in patients >70 or =70 years old with AOC undergoing PDS versus NACT.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bernardini, Marcus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">May, Taymaa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Laframboise, Stephane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferguson, Sarah</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bouchard-Fortier, Genevieve</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cybulska, Paulina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hogen, Liat</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Gibson, Diane M. ELSEVIER</subfield><subfield code="t">Frequency and predictors of missed visits to primary care and eye care providers for annually recommended diabetes preventive care services over a two-year period among U.S. adults with diabetes</subfield><subfield code="d">2017</subfield><subfield code="d">an international journal : official publication of the Society of Gynecologic Oncologists [u.a.]</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000708127</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:162</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:313</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/S0090-8258(21)01245-2</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.11</subfield><subfield code="j">Präventivmedizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">162</subfield><subfield code="j">2021</subfield><subfield code="h">313</subfield><subfield code="y">162.2021, S313-</subfield></datafield></record></collection>
|
| score |
7.402793 |